XML 24 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity (Narrative) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 23, 2017
USD ($)
item
Jan. 31, 2020
shares
Jan. 31, 2019
shares
Jun. 30, 2017
USD ($)
$ / shares
item
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
item
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
item
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Aug. 31, 2017
USD ($)
Oct. 31, 2010
$ / shares
shares
Stockholders' Equity [Line Items]                    
Common Stock, shares authorized | shares         1,000,000,000 1,000,000,000 1,000,000,000     1,000,000,000
Common Stock, par value | $ / shares         $ 0.001 $ 0.001 $ 0.001     $ 0.001
Preferred Stock, shares authorized | shares         50,000,000 50,000,000 50,000,000     50,000,000
Preferred Stock, par value | $ / shares         $ 0.001 $ 0.001 $ 0.001     $ 0.001
Preferred Stock, shares issued | shares         0 0 0      
Preferred Stock, shares outstanding | shares         0 0 0      
Common stock, dividends declared | $ / shares           $ 0        
Voting right of common stock share holders           one        
Voting right of common stock share holdes, number of votes | item           1        
Amount of common stock, preferred stock, depositiry shares, warrants, units or debt securities available in future public offerings                 $ 150,000  
Repayment of notes payable               $ 4,500    
Number of equity compensation plans | item           2        
Accelerated compensation         $ 2,500          
Aggregate intrinsic value outstanding           $ 20,000        
Aggregate intrinsic value exercisable options           $ 14,500        
Stock price | $ / shares           $ 5.14        
Weighted average remaining contractual life for exercisable           4 years 10 months 10 days        
Vested and expected to vest, outstanding | shares           21,231,000        
Vested and expected to vest, aggregate intrinsic value           $ 17,800        
Vested and expected to vest, weighted average exercise price | $ / shares           $ 5.69        
Vested and expected to vest, weighted average remaining contractual life           5 years 1 month 17 days        
Total intrinsic value of options exercised           $ 2,600 $ 5,300 1,700    
Fair value of options vested           2,900 3,900 6,400    
Stock-based compensation cost capitalized in inventory           300 700      
Stock-based compensation           $ 16,401 $ 23,153 $ 20,352    
2010 Plan [Member]                    
Stockholders' Equity [Line Items]                    
Stock option grant, term           10 years        
Stock option grant, vest           4 years        
Stock option grant, vest rate upon first anniversary           25.00%        
Stock option grant, vest rate per month thereafter           2.08%        
Vesting period           4 years        
2010 Director Plan [Member]                    
Stockholders' Equity [Line Items]                    
Stock option grant, term           10 years        
Stock option grant, vest rate upon first anniversary           33.00%        
Stock option grant, vest rate per month thereafter           2.78%        
2010 Director Plan [Member] | Minimum [Member]                    
Stockholders' Equity [Line Items]                    
Stock option grant, vest           1 year        
Vesting period           1 year        
2010 Director Plan [Member] | Maximum [Member]                    
Stockholders' Equity [Line Items]                    
Stock option grant, vest           3 years        
Vesting period           3 years        
2010 Plan and 2010 Director Plan [Member]                    
Stockholders' Equity [Line Items]                    
Common stock reserved for issuance | shares         11,300,000 20,500,000 11,300,000      
ESPP [Member]                    
Stockholders' Equity [Line Items]                    
Common stock reserved for issuance | shares           3,651,066        
Additional common stock reserved for issuance | shares     3,100,000              
Percentage of outstanding common stock used to determine annual plan increase           2.00%        
Number of purchase periods | item           4        
Purchase period of ESPP           6 months        
Percentage of fair market value at which stock can be purchased           85.00%        
Weighted average fair value at grant date | $ / shares           $ 0 $ 1.47 $ 2.28    
Stock-based compensation           $ 500 $ 6,800 $ 3,100    
Common stock purchased under plan | shares           1,306,329 1,674,960 1,289,663    
Cash received from option exercises           $ 2,700 $ 3,400 $ 5,300    
At the Market Offering [Member]                    
Stockholders' Equity [Line Items]                    
Shares issued | shares               3,200,000    
Average common stock price per share | $ / shares               $ 3.86    
Proceeds from issuance of common stock from offering, net of issuance costs               $ 11,865    
Commissions, percentage of gross proceeds       3.00%            
At the Market Offering [Member] | Common Stock                    
Stockholders' Equity [Line Items]                    
Shares issued | shares               3,171,000    
Underwritten Public Equity Offering [Member]                    
Stockholders' Equity [Line Items]                    
Shares issued | shares       17,700,000     30,600,000      
Proceeds from issuance of common stock from offering, net of issuance costs       $ 52,500     $ 97,530 $ 52,530    
Commissions, percentage of gross proceeds       4.00%            
Holders may elect to receive net proceeds from financing activities, percentage           25.00%        
Number of offerings | item             2      
Price per share | $ / shares       $ 3.10 $ 3.38   $ 3.38      
Underwritten Public Equity Offering [Member] | Common Stock                    
Stockholders' Equity [Line Items]                    
Shares issued | shares             30,610,000 17,732,000    
Options outstanding [Member]                    
Stockholders' Equity [Line Items]                    
Exercise price, lower range | $ / shares                  
Weighted average remaining contractual life           1 year 6 months        
Weighted average fair value at grant date | $ / shares           $ 1.50 $ 3.08      
Stock-based compensation           $ 11,000 $ 15,500 $ 17,200    
Options granted | shares                  
Unrecognized compensation costs           $ 5,600        
Cash received from option exercises           $ 5,900 $ 6,300 $ 3,600    
Options outstanding [Member] | $1.16 – 16.00 [Member]                    
Stockholders' Equity [Line Items]                    
Exercise price, lower range | $ / shares           $ 1.16 $ 1.16      
Exercise price, upper range | $ / shares           $ 16.00 $ 16.00      
Options outstanding [Member] | $2.54 – 16.00 [Member]                    
Stockholders' Equity [Line Items]                    
Options expired | shares           900,000        
Exercise price, lower range | $ / shares           $ 2.54        
Exercise price, upper range | $ / shares           16.00        
Options expired, weighted average exercise price | $ / shares           $ 9.90        
Time-Based Restricted Stock Units (RSUs) [Member]                    
Stockholders' Equity [Line Items]                    
Stock option grant, vest           4 years        
Ratio of number of shares into which the share instrument may be converted | shares           1        
Vesting period           4 years        
Time-Based Restricted Stock Units (RSUs) [Member] | 2010 Plan [Member]                    
Stockholders' Equity [Line Items]                    
Stock-based compensation           $ 4,900        
Subsequent Event [Member] | 2010 Plan [Member]                    
Stockholders' Equity [Line Items]                    
Additional common stock reserved for issuance | shares   7,700,000                
Subsequent Event [Member] | 2010 Director Plan [Member]                    
Stockholders' Equity [Line Items]                    
Additional common stock reserved for issuance | shares   1,500,000                
Notes [Member]                    
Stockholders' Equity [Line Items]                    
Repayment of notes payable $ 4,500     $ 4,500            
Number of Notes holders paid | item 1     1            
Share-based Compensation Award, Tranche One, Two, Three and Four [Member] | Time-Based Restricted Stock Units (RSUs) [Member]                    
Stockholders' Equity [Line Items]                    
Vesting percentage           25.00%